ShoulderUp Technology Acquisition Completes Business Combination with SEE ID
PorAinvest
viernes, 20 de junio de 2025, 8:00 am ET2 min de lectura
CAI--
The Business Combination, approved at a special meeting of Nova Vision shareholders on September 12, 2024, signals a new phase in Real Messenger’s journey to empower the real estate industry with advanced digital solutions. This business combination marks a pivotal step for Real Messenger as it continues to build a connected, digital ecosystem for the real estate community [1].
Real Messenger, with over 1 million users, offers a seamless platform where agents, buyers, sellers, and even those simply exploring real estate content or services can find value across a growing, global network. The platform is trusted by users across 35 countries, with notable growth in key markets such as the U.S., U.K., and Australia [1].
Thomas Ma, CEO and Founder of Real Messenger, commented, "Today marks an exciting milestone for Real Messenger. Our approach to proptech has always been guided by a belief that lasting impact comes from rethinking how people connect within the real estate world. By building a social network focused on real estate relationships, we’re creating a foundational layer that puts people and connections at the center of the real estate journey. This Nasdaq listing represents the first step in what I believe will be a transformative path, positioning Real Messenger to bring new value to stakeholders and set a new standard for what a connected real estate ecosystem can accomplish."
Meanwhile, US stocks were mixed as investors await the Federal Reserve's policy decision. The Nasdaq was down near 0.2%, while S&P futures dropped near 0.15%. In separate news, Caris Life Sciences raised $494 million in its US IPO, and the company's shares rose in its Nasdaq debut [2].
Caris Life Sciences priced its IPO of 23,529,412 shares at $21 per share, raising a total of $494.1 million in gross proceeds. The firm also granted the underwriters a 30-day option to purchase up to an additional 3,529,411 shares of its common stock at the IPO price, potentially adding $74.1 million in gross proceeds [2].
The company offers a portfolio of cancer comprehensive molecular profiling tests that use next-generation sequencing, artificial intelligence, and machine learning. Caris Life Sciences has created a large-scale, multimodal clinico-genomic database using more than 6.5 million tests run on more than 849,000 cases [2].
References:
[1] https://www.businesswire.com/news/home/20241119557693/en/Real-Messenger-and-Nova-Vision-Acquisition-Corp.-Announce-Closing-of-Business-Combination
[2] https://www.360dx.com/cancer/caris-life-sciences-prices-494m-ipo
MESA--
RMSG--
ShoulderUp Technology Acquisition has completed its business combination with SEE ID. US stocks were mixed as investors await the Federal Reserve's policy decision. The Nasdaq was down near 0.2%, while S&P futures dropped near 0.15%. Caris Life Sciences raised $494 million in its US IPO, and the company's shares rose in its Nasdaq debut.
Costa Mesa, Calif.--(BUSINESS WIRE)--Real Messenger Holdings Limited ("Real Messenger" or the "Company"), an innovative chat-based platform reimagining real estate connections, and Nova Vision Acquisition Corp. ("Nova Vision") (Nasdaq: NOVV, NOVVR, NOVVW, and NOVVU), a special purpose acquisition company ("SPAC"), announced today the completion of their previously announced business combination (the "Business Combination"). The combined company will operate under the name Real Messenger Corporation and is set to begin trading on Nasdaq under the ticker symbols “RMSG” and “RMSGW” on November 20, 2024 [1].The Business Combination, approved at a special meeting of Nova Vision shareholders on September 12, 2024, signals a new phase in Real Messenger’s journey to empower the real estate industry with advanced digital solutions. This business combination marks a pivotal step for Real Messenger as it continues to build a connected, digital ecosystem for the real estate community [1].
Real Messenger, with over 1 million users, offers a seamless platform where agents, buyers, sellers, and even those simply exploring real estate content or services can find value across a growing, global network. The platform is trusted by users across 35 countries, with notable growth in key markets such as the U.S., U.K., and Australia [1].
Thomas Ma, CEO and Founder of Real Messenger, commented, "Today marks an exciting milestone for Real Messenger. Our approach to proptech has always been guided by a belief that lasting impact comes from rethinking how people connect within the real estate world. By building a social network focused on real estate relationships, we’re creating a foundational layer that puts people and connections at the center of the real estate journey. This Nasdaq listing represents the first step in what I believe will be a transformative path, positioning Real Messenger to bring new value to stakeholders and set a new standard for what a connected real estate ecosystem can accomplish."
Meanwhile, US stocks were mixed as investors await the Federal Reserve's policy decision. The Nasdaq was down near 0.2%, while S&P futures dropped near 0.15%. In separate news, Caris Life Sciences raised $494 million in its US IPO, and the company's shares rose in its Nasdaq debut [2].
Caris Life Sciences priced its IPO of 23,529,412 shares at $21 per share, raising a total of $494.1 million in gross proceeds. The firm also granted the underwriters a 30-day option to purchase up to an additional 3,529,411 shares of its common stock at the IPO price, potentially adding $74.1 million in gross proceeds [2].
The company offers a portfolio of cancer comprehensive molecular profiling tests that use next-generation sequencing, artificial intelligence, and machine learning. Caris Life Sciences has created a large-scale, multimodal clinico-genomic database using more than 6.5 million tests run on more than 849,000 cases [2].
References:
[1] https://www.businesswire.com/news/home/20241119557693/en/Real-Messenger-and-Nova-Vision-Acquisition-Corp.-Announce-Closing-of-Business-Combination
[2] https://www.360dx.com/cancer/caris-life-sciences-prices-494m-ipo
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios